Life Gilead's Refusal to Supply Lenacapavir Raises Concerns for HIV Prevention Efforts Doctors Without Borders has criticized Gilead Sciences for declining to provide lenacapavir, a crucial HIV prevention drug, after lengthy negotiations. Editorial Staff Mar 30
Life Exploring the Intersection of Diet and Mental Health: Insights from Metabolic Psychiatry Shebani Sethi, a Stanford psychiatrist, is pioneering research in metabolic psychiatry, focusing on how dietary choices may impact serious mental health disorders. Editorial Staff Mar 30
Life Implementation Insights on 2025 Reconciliation Law: Medicaid Work Requirements An analysis of state and national data reveals the ongoing implementation of Medicaid work requirements under the 2025 Reconciliation Law. Editorial Staff Mar 30
Life AI-Driven Analysis of Brain Scans Enhances Early Alzheimer’s Detection Researchers are leveraging AI technology to analyze brain scans, achieving a prediction accuracy of nearly 93 percent for Alzheimer’s disease. Editorial Staff Mar 30
Life Long-term Risks of Lead Exposure on Cardiovascular Health Identified A recent study published in JAMA highlights the prolonged effects of lead exposure on cardiovascular health, emphasizing its impact on blood pressure and vessel integrity. Editorial Staff Mar 30
Life Health Care Employment Trends: Growth and Contraction The health care sector has significantly contributed to the expansion of the American workforce, yet certain areas within this industry are experiencing reductions. Editorial Staff Mar 30
Life Biogen's Mid-Stage Lupus Drug Study Shows Positive Skin Clearance Results Biogen's recent mid-stage study reveals promising results in skin clearance for lupus treatment, indicating potential advancements in therapeutic options for patients. Editorial Staff Mar 30
Life Raw Dairy Company Denies Link to E. coli Outbreak A raw dairy company has publicly denied any connection to a recent E. coli outbreak, emphasizing its commitment to safety and quality standards. Editorial Staff Mar 30
Life Trump Administration Advances Drug Pricing Legislation with Pharma Stakeholders The White House has initiated discussions on drug pricing reforms by sharing drafted legislative text with major pharmaceutical companies, while also addressing Chinese biotech licensing. Editorial Staff Mar 30
Life Key Infrastructure Challenges Await New CDC Director The incoming CDC director will encounter significant operational hurdles that could impact public health infrastructure and response capabilities. Editorial Staff Mar 30
Life Stagnation in Health Care Job Growth Amid Insurer Job Cuts Major health insurers are reducing their workforce, and potential Medicaid cuts may lead to further layoffs in hospitals, impacting overall health care infrastructure. Editorial Staff Mar 30
Life Honoring Barry Bloom: Contributions to Public Health Infrastructure Marc Lipsitch and Yonatan Grad reflect on the impact of Barry R. Bloom's work in public health, emphasizing his role as a mentor and scientist. Editorial Staff Mar 30
Life Impending Reforms in Pharmacy Benefit Managers: A Technical Overview Washington is approaching significant reforms in Pharmacy Benefit Managers (PBMs), which are critical fiduciaries within the healthcare system. Editorial Staff Mar 30
Life Lilly Partners with Insilico Medicine on $2.75 Billion Drug Development Deal Lilly has entered a commercialization agreement with AI-driven Insilico Medicine, featuring an upfront payment of $115 million and potential biobucks reaching $2.75 billion. Editorial Staff Mar 29
Life Medicaid Enrollment and Unwinding Data Overview The latest Medicaid data tracker provides insights into state-level renewals and disenrollments, alongside monthly enrollment figures during the unwinding phase. Editorial Staff Mar 27
Life FDA Prioritizes Food Safety and Labeling in Legislative Briefing The FDA's recent briefing to lawmakers highlighted key priorities including infant formula safety, food labeling updates, ultraprocessed food definitions, and enhanced inspections of processing facilities. Editorial Staff Mar 27
Life U.S. Global Health Funding Tracker Launches for Country-Level Insights The newly launched U.S. Global Health Country-Level Funding Tracker offers detailed insights into funding allocations across various health programs and countries. Editorial Staff Mar 27
Life White House Seeks Pharma Support for Drug Pricing Legislation The White House is actively engaging with pharmaceutical companies to garner support for upcoming drug pricing legislation, emphasizing affordability as a key election issue. Editorial Staff Mar 27
Life China's Biotech Expansion and Its Global Implications China's rapidly growing biotech sector is reshaping international scientific collaboration, particularly in light of recent NIH actions that may hinder partnerships. Editorial Staff Mar 27
Life NIH Restrictions on Foreign Institutions: Implications for Global Health Research NIH restrictions are poised to significantly affect funding for foreign institutions, impacting international research collaborations and potentially delaying health advancements. Editorial Staff Mar 27